Skip to main content
Explore URMC

UR Medicine

menu
UR Medicine / Neurosurgery / News, Events & CMEs

News, Events and CMEs

From breakthroughs in neurosurgery research, to patients and procedures that are in the news, to information on upcoming events, you can find the latest information here.

Please check back regularly for updated news and events about UR Medicine Neurosurgery.

20182017201620152014 Archive

Words Matter When Talking About Pain With Your Doctor

Monday, July 23, 2018

If you're in the hospital or a doctor's office with a painful problem, you'll likely be asked to rate your pain on a scale of 0 to 10 – with 0 meaning no pain at all and 10 indicating the worst pain you can imagine. But many doctors and nurses say this rating system isn't working and they're trying a new approach.

The numeric pain scale may just be too simplistic, says Dr. John Markman, director of the Translational Pain Research Program at the University of Rochester School of Medicine and Dentistry. It can lead doctors to "treat by numbers," he says and as a result, patients may not be getting the most effective treatment for their pain.

Take the case of 33-year-old Adam Rosette, who was recently hospitalized for fibrous dysplasia, a bone disorder that made it nearly impossible for him to chew or even speak. After brain surgery to remove benign tumors related to the disorder, he was definitely in pain. But he was reluctant to label the pain too high.

"I don't think I ever answered higher than a '7' because an '8' would be, in my mind, like I'm missing half of my body or a limb," he recalls.

Read More: Words Matter When Talking About Pain With Your Doctor

AHA Grants Will Accelerate Search for New Stroke Therapies

Wednesday, June 27, 2018

A series of awards from the American Heart Association (AHA) to a team of researchers at the University of Rochester Medical Center (URMC) will focus on the development of new treatments to thwart the damage in the brain caused by stroke.

One of the research projects brings together experts in stroke, cardiovascular biology, platelet biology, and peptide chemistry. Marc Halterman, M.D., Ph.D., with the URMC Center for Neurotherapeutics Discovery, Scott Cameron, M.D., Ph.D., and Craig Morrell, D.V.M., Ph.D., with the URMC Aab Cardiovascular Research Institute, and Bradley Nilsson, Ph.D., with the University of Rochester Department of Chemistry will focus on the role that platelets play in acute brain injury and inflammation during stroke.

Platelets serve an important role in protecting against blood loss and repairing injured blood vessels. However, during a stroke the inflammatory properties of platelets can interfere with the restoration of blood flow once the clot in the brain is removed, particularly in micro-vessels, which can lead to permanent damage of brain tissue.

The research team will build synthetic peptides that activate platelets to study the phenomenon – which is called no-reflow – in an effort to identify specific switches within platelets that can be turned off and limit the cells’ inflammatory functions without blocking their ability to prevent bleeding.

Two AHA pre-doctoral fellowship awards Kathleen Gates and Jonathan Bartko in Halterman’s lab will support research that examines the link between an immune system response triggered by stroke in the lungs that can exacerbate damage in the brain and investigate the cellular mechanisms that determine whether or not brain cells die following stroke.

A final AHA award to the Halterman lab will seek to identify new drug targets by focusing on specific proteins activated during stroke that are suspected to play an important role in determining the survival of neurons.

Collectively, the AHA Collaborative Sciences Award, Pre-Doctoral, and Innovation awards represent $1.09 million in funding.

Read More: AHA Grants Will Accelerate Search for New Stroke Therapies

UR Medicine Recognized for Excellence in Stroke Care

Monday, June 11, 2018

The American Heart Association/American Stroke Association (AHA/ASA) has once again honored the UR Medicine Strong Memorial Hospital for having achieved the highest standard of care for stroke. This award identifies hospitals that provide care that can speed the recovery and reduce death and disability for stroke patients.

Strong Memorial Hospital has received the 2018 AHA/ASA Get With The Guidelines program’s Stroke Gold Plus Quality Achievement Award.  The hospital was also recognized for the Target: Stroke Honor Role Elite Plus designation, which identifies hospitals that have consistently and successfully reduced door-to-needle time – the window of time between a stroke victim’s arrival at the hospital, the diagnosis of an acute ischemic stroke, and the administration of the clot-busting drug tPA.  If given intravenously in the first four and a half hours after the start of stroke symptoms, tPA has been shown to significantly reduce the effects of stroke and lessen the chance of permanent disability.

Read More: UR Medicine Recognized for Excellence in Stroke Care

Wilmot announces new Pilot Award recipients

Monday, April 30, 2018

Wilmot’s competitive seed-grant program aims to fund research projects that will generate preliminary data necessary to potentially apply for federal funding in the future. Thanks to financial support from two community organizations – Adding Candles for a Cure and the Edelman Gardner Cancer Research Foundation – four projects have received funding that started Jan. 1.

Mark Noble, Ph.D., Professor in the departments of Biomedical Genetics and Neuroscience, received a $50,000 grant for his project titled, “A biomarker for a novel glioblastoma (GBM) vulnerability.” The co-investigators for this project are Kevin Walter, M.D., Mahlon Johnson, M.D., Ph.D., Nimish Mohile, M.D., and Peggy Auinger, M.S.

Bradford Mahon, Ph.D., Assistant Professor in the Departments of Neurology and Neurosurgery, received a $50,000 grant for his project seeking to demonstrate feasibility and preliminary efficacy of advanced MRI mapping in improving outcome in patients with glioblastoma. Kevin Walter, M.D., is the co-investigator for this project.

Congratulations to all Wilmot pilot grant recipients.

Regional Providers Gather in Rochester to Discuss Advances in Stroke Care

Wednesday, March 28, 2018

By Mark Michaud

Providers from across upstate New York are gathering tomorrow for UR Medicine’s 7h annual Stroke Treatment Alliance of Rochester – New York (STAR-NY) Stroke Management Symposium. The meeting – which attracts more than 400 participants annually – will highlight pre-hospital care, new medical and surgical advances, a regional approach to stroke care, and recovery and prevention.

Participants in the conference, held at the Hyatt Regency in Rochester, attracts over 400 clinicians annually, include primary care physicians, internists, neurologists, neurosurgeons, emergency physicians, family physicians, radiologists, cardiologists, nurses, physician assistants, nurse practitioners and EMS personnel who care for patients with cerebrovascular disorders.

Topics that will be discussed include the challenges of stroke care in community and rural hospital settings, protocols to identify and transfer acute stroke patients, developing a regional approach to stroke care, advances in medical and surgical treatment technology, medical management of at-risk patients, and rehabilitation, with a focus on the adoption of new mobile technologies that can help physicians and EMS personnel diagnose start treatment for stroke patients before they reach the hospital.

The sessions will be led by neurology, and neurosurgery, and cardiothoracic surgery faculty from UR Medicine and Cayuga Medical Center, with a guest speaker from Memorial Hermann - Texas Medical Center who will describe efforts to improve pre-hospital stroke care through the use of advanced technologies.

For more information, visit: https://www.urmc.rochester.edu/stroke-treatment-alliance-rochester.aspx

Read More: Regional Providers Gather in Rochester to Discuss Advances in Stroke Care

John Markman Elected to American Pain Society Board

Friday, March 16, 2018

markman

John Markman, M.D.

John Markman, M.D., professor of Neurosurgery and Neurology, was elected to the board of the American Pain Society in March of 2018.

The American Pain Society is the nation’s leading organization of scientists, physicians, and allied professionals focused on increasing knowledge of pain and transforming clinical practice and policy to reduce pain-related suffering. Markman founded and directs the University’s Neuromedicine Pain Management Center and Translational Pain Research Program. Together these programs were previously recognized as a Center of Excellence by the American Pain Society.

Congratulations Dr. Markman!